| Pregnancy |
1 |
1 |
| Otolaryngology |
0 |
1 |
| Antibiotics |
0 |
0.88 |
| Vagina |
0 |
0.56 |
| Urinary Tract Infection |
0 |
0.52 |
| Vaginal Discharge |
0 |
0.45 |
| Vaginal Delivery |
0 |
0.42 |
| Prophylaxis |
0 |
0.3 |
| Skin and Soft Tissue Infection |
0 |
0.28 |
| Endometritis |
0 |
0.26 |
| Allergy |
0 |
0.23 |
| Chlamydial Infection |
0 |
0.23 |
| Intravenous |
0 |
0.23 |
| Fever |
0 |
0.19 |
| Fungal Infection |
0 |
0.19 |
| Gonorrhea |
0 |
0.19 |
| Mastitis |
0 |
0.17 |
| Pneumonia |
0 |
0.16 |
| Vulvovaginal Candidiasis |
0 |
0.15 |
| Acute Cystitis |
0 |
0.11 |
| Acute Pyelonephritis |
0 |
0.11 |
| Candidiasis |
0 |
0.11 |
| Catheterization |
0 |
0.11 |
| Cesarean Delivery |
0 |
0.11 |
| Infective Cystitis |
0 |
0.11 |
| Nephrotoxicity |
0 |
0.11 |
| Ototoxicity |
0 |
0.11 |
| Rectum |
0 |
0.11 |
| Trichomoniasis |
0 |
0.11 |
| Urethra |
0 |
0.11 |
| Urethritis |
0 |
0.11 |
| Wound Infection |
0 |
0.11 |
| Breast Abscess |
0 |
0.09 |
| Syphilis |
0 |
0.09 |
| Tropical Diseases |
0 |
0.09 |
| Bacterial Vaginosis |
0 |
0.07 |
| Bladder |
0 |
0.07 |
| Body Mass Index |
0 |
0.07 |
| Breast |
0 |
0.07 |
| Cystitis |
0 |
0.07 |
| Face |
0 |
0.07 |
| First Trimester Pregnancy |
0 |
0.07 |
| Generics |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Postpartum |
0 |
0.07 |
| Preterm Labor |
0 |
0.07 |
| Pyelonephritis |
0 |
0.07 |
| Tachycardia |
0 |
0.07 |
| Toxicology |
0 |
0.07 |
| Wound |
0 |
0.07 |
| Wound Management |
0 |
0.07 |
| Acute Bacterial Skin Infections |
0 |
0.06 |
| Arrhythmia |
0 |
0.06 |
| MRSA |
0 |
0.05 |
| Patient Safety |
0 |
0.05 |
| Sepsis |
0 |
0.05 |
| Spontaneous Abortion |
0 |
0.05 |
| Umbilical Cord |
0 |
0.05 |
| Abortion |
0 |
0.04 |
| Abscess |
0 |
0.04 |
| Adherence |
0 |
0.04 |
| Adverse Effects |
0 |
0.04 |
| Amniocentesis |
0 |
0.04 |
| Antibiotic Resistance |
0 |
0.04 |
| Arthritis |
0 |
0.04 |
| Aspiration |
0 |
0.04 |
| Candida |
0 |
0.04 |
| Choanal Atresia |
0 |
0.04 |
| Diaphragmatic Hernia |
0 |
0.04 |
| Diarrhea |
0 |
0.04 |
| Drug Resistance |
0 |
0.04 |
| Epithelium |
0 |
0.04 |
| Escherichia coli |
0 |
0.04 |
| Fitz-Hugh-Curtis Syndrome |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Gardnerella |
0 |
0.04 |
| Gonococcal Infection |
0 |
0.04 |
| Gonococcus |
0 |
0.04 |
| Heart |
0 |
0.04 |
| Hernia |
0 |
0.04 |
| Hormonal Therapy |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Inpatient Care |
0 |
0.04 |
| Insurance |
0 |
0.04 |
| Kidney |
0 |
0.04 |
| Klebsiella Infections |
0 |
0.04 |
| Lactation |
0 |
0.04 |
| Liver |
0 |
0.04 |
| Meningitis |
0 |
0.04 |
| Neonatal Pneumonia |
0 |
0.04 |
| Neural Tube Defects |
0 |
0.04 |
| Newborn |
0 |
0.04 |
| Nipple Discharge |
0 |
0.04 |
| Obesity |
0 |
0.04 |
| Orbit |
0 |
0.04 |
| Pain Management |
0 |
0.04 |
| Patient History |
0 |
0.04 |
| Proctitis |
0 |
0.04 |
| Pruritus |
0 |
0.04 |
| Refractory |
0 |
0.04 |
| Revenue and Practice Management |
0 |
0.04 |
| Staphylococcal Infection |
0 |
0.04 |
| Staphylococcus Aureus Infection |
0 |
0.04 |
| Surgery |
0 |
0.04 |
| Topical Medication |
0 |
0.04 |
| Umbilical |
0 |
0.04 |
| Weakness |
0 |
0.04 |
| Dermatitis |
0 |
0.02 |
| Meningococcal Disease |
0 |
0.02 |
| Prenatal Screening and Diagnostics |
0 |
0.02 |
| Vaginitis |
0 |
0.02 |